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background: Radial access is the object of increasing interest 
for interventional cardiologists, providing several advantages, 
including the reduced rates of major bleeding, which is related 
to increased risk of death and ischemic events. However, 
its role as an access technique in primary percutaneous 
coronary intervention (PCI) remains controversial due to 
the greater complexity of the procedure and possible delay 
in obtaining myocardial reperfusion, compared to femoral 
access. Methods: Retrospective study including consecutive 
patients with a diagnosis of ST-elevation acute myocardial 
infarction (STEMI) undergoing primary PCI by radial access. 
Clinical, angiographic and procedure characteristics were 
analyzed, as well as early and late follow-up outcomes. 
results: From October 2010 to February 2012, 61 patients 
underwent primary PCI by radial access. Mean age was 59 
± 11.1 years, 24.6% were female and 21.3% were diabetic. 
Door-to-balloon time was 126.1 ± 44.7 minutes, fluoroscopy 
time was 16.1 ± 9.5 minutes, angiographic success was 
achieved in 98.5%, with myocardial blush grades 2 and 3 
in 77.4% and ST-segment elevation resolution > 50% at 90 
minutes in 70.5% of the patients. Hospital mortality was 
6.6% and the rate of major bleeding was 1.6%. In the late 
follow-up, clinical restenosis was observed in 7.2% and 
additional deaths in 3.5% of the patients. Conclusions: The 
use of radial access for primary PCI is safe and effective 
when performed at experienced centers and did not pres-
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Intervenção Coronária Percutânea por Acesso 
Transradial em Pacientes com Infarto Agudo do 
Miocárdio com Supradesnivelamento do Segmento ST
Introdução: A via radial é objeto de interesse crescente de 
cardiologistas intervencionistas, por oferecer diversas vantagens, 
entre elas a redução da taxa de sangramento maior, associado 
a maior risco de morte e eventos isquêmicos. Entretanto, sua 
utilização como via de acesso na intervenção coronária per-
cutânea (ICP) primária é motivo de controvérsias, pela maior 
complexidade do procedimento e pelo possível retardo para 
se obter a reperfusão miocárdica, quando comparada à via 
femoral. Métodos: Estudo retrospectivo, que incluiu pacientes 
consecutivos com diagnóstico de infarto agudo do miocárdio com 
supradesnivelamento do segmento ST (IAMCSST) submetidos a 
ICP primária por via radial. Foram analisados os perfis clínico, 
angiográfico e do procedimento, assim como a evolução tanto 
inicial como tardia. resultados: Entre outubro de 2010 e fevereiro 
de 2012, 61 pacientes foram submetidos a ICP primária por via 
radial. A média de idade foi de 59 + 11,1 anos, 24,6% eram 
do sexo feminino e 21,3% eram diabéticos. O tempo porta-
-balão foi de 126,1 + 44,7 minutos, o tempo de fluoroscopia 
foi de 16,1 + 9,5 minutos, o sucesso angiográfico foi alcançado 
em 98,5%, com obtenção de blush miocárdico graus 2 ou 3 em 
77,4%, e resolução do segmento ST > 50% aos 90 minutos em 
70,5% dos pacientes. A mortalidade hospitalar foi de 6,6% e 
a taxa de sangramento grave foi de 1,6%. Na evolução tardia, 
reestenose clínica ocorreu em 7,2% e óbitos adicionais, em 
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ent delayed reperfusion when compared to historical data, 
showing low risk of major bleeding.
 
 
 
DESCrIPTorS: Myocardial infarction. Radial artery. Angio-
plasty. Hemorrhage.
3,5% dos pacientes. Conclusões: A utilização da via radial para 
ICP primária é segura e eficaz quando realizada em serviços 
familiarizados com a técnica, não apresentou retardo para a 
reperfusão, comparativamente a dados históricos, e demonstrou 
baixo risco de sangramento maior.
DESCrITorES: Infarto do miocárdio. Artéria radial. Angioplas-
tia. Hemorragia.
r adial access is the subject of increasing interest regarding diagnostic and therapeutic procedures worldwide and in Brazil. It has several advantages 
when compared to femoral access, such as convenience 
for the patient immediately after the procedure, ear-
lier return to activities, decreased length of stay with 
consequent reduction of hospital costs, and a low 
complication rate at the puncture site. The low risk of 
puncture site complications leads to a reduced rate of 
major bleeding, which, in turn, is associated with a 
decreased risk of death and ischaemic events.1–5
This access is particularly important in the setting 
of acute myocardial infarction with ST-segment elevation 
(STEMI), in which the use of antiplatelet and antithrom-
botic therapies is more aggressive, increasing the risk 
of bleeding. However, the role of percutaneous coronary 
intervention (PCI) through radial access in STEMI remains 
controversial, for reasons related to the complexity of 
the procedure and its possible delay in obtaining early 
reperfusion, the main goal of primary PCI.
This study aimed to evaluate the clinical, angio-
graphic and procedural profiles, as well as the initial 
and late evolution in patients with STEMI undergoing 
primary PCI through radial access in a non-selected 
population representative of daily clinical practice.
Methods
This was a retrospective study that included all 
consecutive patients with STEMI treated with primary 
PCI by radial access in the first 12 hours or up to 24 
hours with persistent pain or hemodynamic instability. 
Patients with a previous CABG, patients with chronic 
renal failure, those on dialysis with a fistula in their 
upper right limb, and those in cardiogenic shock with 
no radial pulse were excluded. Patients in cardiogenic 
shock who responded to initial therapy with vasoac-
tive amines and had a radial pulse on arrival to the 
catheterization laboratory were included.
The radial artery puncture was performed with the 
patient positioned with the right arm extended to the 
side, with his or her hand in the supine position. Local 
anaesthesia was used and was performed with 2 to 3 
mL of 2% lidocaine. A Jelco 20 was used to puncture 
the artery, and after puncture, arterial sheaths specific 
to the radial artery, which were 5-F to 7-F and 11 cm 
in length, were inserted. After the procedure, the arte-
rial sheath was removed in the room without heparin 
reversal, and a compression bandage applied, and then 
removed, usually two hours after the procedure.
All patients received a loading dose of 300 mg of 
acetylsalicylic acid and 600 mg of clopidogrel, followed 
by maintenance doses of 100 mg and 75 mg a day, 
respectively, and unfractionated heparin intravenously, 
at a dose of 70 to 100 U/kg.
The patients were followed after discharge, and 
follow-up occurred at one month, three months, six 
months, and one year through medical consultation 
or telephone contact.
Bleeding was defined according to the Throm-
bolysis in Myocardial Infarction6 criteria (TIMI: mini-
mal, any clinical sign of bleeding associated with a 
decrease in hemoglobin < 3 g/dL; minor, any clinical 
sign of bleeding associated with a decrease in he-
moglobin of 3 g/dL to 5 g/dL; and major, intracra-
nial bleeding, signs of clinically significant bleeding 
associated with decrease in hemoglobin > 5 g/dL, or 
fatal bleeding) and the Bleeding Academic Research 
Consortium (BARC: type 0, no bleeding; type 1, 
minor bleeding that does not require medical atten-
tion or hospitalization; type 2, any sign of bleeding 
that does not fit types 3, 4, or 5, but has at least 
one of non-surgical medical intervention, need for 
hospitalization, or increased level of care, or need 
for clinical evaluation; type 3A, bleeding associated 
with a decrease in hemoglobin of 3 g/dL to 5 g/dL 
or bleeding requiring blood transfusion; type 3B, bleed-
ing associated with a decrease in hemoglobin > 5 g/dL, 
cardiac tamponade, bleeding requiring surgical treatment 
for control, except dental, nasal, skin, hemorrhoids, or 
bleeding requiring the use of vasoactive drugs; type 3C, 
intracranial bleeding except micro-bleeding or hemor-
rhagic transformation, different subcategories of bleeding 
confirmed by autopsy, imaging tests or peritoneal or 
intraocular bleeding that compromises eyesight; type 4, 
bleeding related to coronary artery bypass graft (CABG) 
surgery; and type 5,fatal bleeding).
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The TIMI criteria were used to define reinfarction 
after the procedure,6 which states that for patients within 
48 hours of the index procedure, three conditions must 
be present: documentation that creatine kinase MB 
fraction (CK-MB) was decreased (or total CK, when 
CK-MB is not available); the CK-MB obtained at least 
four hours after the procedure is > three times the up-
per limit of normal levels (or total CK, when CK-MB 
is not available); and an increase in CK-MB levels of 
at least 50% above the previous value.
Angiographic success was defined as a stenosis 
< 30% of the diameter with final TIMI 3 flow. The 
stent thrombosis was classified as acute, subacute, late, 
or very late; and as possible, probable, and definitive 
according to the criteria of the Academic Research 
Consortium (ARC).8
Continuous variables were expressed as means 
and standard deviations and categorical variables as 
numbers and percentages.
Results
Between October 2010 and February 2012, 61 
consecutive patients with STEMI underwent transradial 
PCI, with 71 lesions treated and 77 stents implanted. 
Of these patients, 26 (42.6%) were initially treated in 
basic health units in small neighbouring towns, with no 
alternative but to transfer them to the referral center, 
which was performed by the Mobile Emergency Service 
(Serviço de Atendimento Móvel de Urgência – SAMU). 
The mean age was 59 ± 11.1 years, 24.6% were females 
and 21.3% were diabetics. Most patients had a TIMI risk 
score of 2 to 7 and were Killip functional class I, and 
six (9.8%) were in cardiogenic shock (Table 1).
Regarding the angiographic characteristics, 34.4% 
cases were single vessel disease, 31.1% were two vessel, 
and 34.4% were three vessel. Most lesions were type 
B2 or C (84.5%) according to the classification of the 
American Heart Association (AHA) and type III or IV 
according to the Society for Cardiac Angiography and 
Interventions (Table 2).
The time between symptom onset and hospital arri val 
(Dt) was 5.5 ± 4.2 hours and the door-to-balloon time 
was 126.1 ± 44.7 minutes. The 61 patients presented 
71 lesions; 77 stents were implanted, thrombus aspira-
tion catheters were used in 21.3%, and 81.7% were 
pre-dilated. The mean fluoroscopy time was 16.1 ± 9.5 
minutes. It was necessary to change the route of access 
to the femoral artery in three patients (4.9%), one due 
to severe spasm that did not resolve with vasodilators 
and sedation, another due to arteria lusoria, and another 
due to significant radial artery tortuosity that prevented 
catheter progression. The glycoprotein IIb/IIIa inhibitor 
abciximab was used in 37.7% of cases, at the discretion 
of the operator. Angiographic success was achieved in 
98.5%, with myocardial blush grade 2 or 3 in 77.4% 
and > 50% resolution of the ST-segment elevation at 
90 minutes in 70.5% of patients (Tables 3 and 4).
Regarding in-hospital evolution and outcomes up 
to 30 days (Table 5), clinical success was achieved in 
90.2%, and there were two (2.8%) cases of AMI due to 
subacute stent thrombosis. In those two cases, there was 
an interruption in the clopidogrel regimen (one on the 
fifth day and the other on the eighth day post-PCI, after 
hospital discharge); these patients underwent re-operation 
through percutaneous reintervention. There were four 
deaths (6.6%), three from cardiac causes (patients with 
cardiogenic shock were included in the sample), and 
one from sepsis secondary to pneumonia associated 
with mechanical ventilation. Bleeding occurred in three 
patients, two of which were minor (classified as minimal 
by the TIMI criteria and 1 and 2 by BARC criteria) and 
one of which was major (major and type 3B by TIMI and 
BARC criteria, respectively). The major bleeding occurred 
in one of the patients whose access was changed to the 
femoral artery and required vascular surgery. The mean 
hospital stay was 5.2 ± 5.8 days. Table 6 presents the 
drugs prescribed at hospital discharge.
TAbLE 1 
baseline clinical characteristics of patients who 
underwent primary percutaneous coronary 
intervention through radial access
n = 61
Age, years 59 ± 11.1
Female gender, n (%) 15 (24.6) 
Systemic arterial hypertension, n (%) 50 (82) 
Dyslipidaemia, n (%) 29 (47.5) 
Smoking, n (%) 19 (31.1) 
Diabetes mellitus, n (%) 13 (21.3) 
Family history of CAD, n (%) 12 (19.7) 
Chronic renal failure, n (%) 22 (36.1) 
TIMI risk, n (%)
< 2 3 (4.9)
2 to 7 48 (78.7)
> 7 10 (16.4)
Killip functional class, n (%)
I 45 (73.7)
II 7 (11.4)
III 3 (4.9)
IV 6 (9.8)
CAD = coronary artery disease; n = number of patients,  
TIMI = Thrombolysis In Myocardial Infarction.
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The mean follow-up time was 146.7 ± 116.5 days, 
with 94.7% of patients followed for three months, 
91.2% for six months, and 61.4% for one year. Dur-
ing this period, 29.8% of the patients needed a new 
intervention, of which 21% were percutaneous and 
8.8% were surgical. The majority (20.8%) underwent 
a second surgery to treat lesions that were not ad-
dressed in the acute phase, because only the culprit 
artery was treated in the acute phase, except in cases 
of cardiogenic shock. The clinical restenosis rate was 
7.2%. There were two additional deaths (3.5%), both 
due to non-cardiac causes: one from complications of 
peripheral arterial disease and another from a massive 
pulmonary embolism. There were no cases of AMI in 
this period (Table 7).
TAbLE 2 
Angiographic characteristics of patients who 
underwent primary percutaneous coronary 
intervention through radial access
n = 61 patients/ 
71 lesions
Affected arteries, n (%)
One vessel 21 (34.4) 
Two vessel 19 (31.1) 
Three vessel 21 (34.4) 
Bifurcation, n (%) 13 (18.3)
Syntax score, n (%)
0-22 37 (60.7)
23-32 17 (27.9)
> 33 7(11.4) 
AHA classification, n (%)
A 0
B1 11 (15.5) 
B2 or C 60 (84.5)
SCAI classification, n (%)
I 14 (19.7) 
II 7 (9.9) 
III 23 (32.4)
IV 27 (38)
Myocardial blush post-PCI, n (%)
0 3 (4.2)
1 13 (18.3)
2 26 (36.6)
3 29 (40.8)
AHA = American Heart Association; PCI = percutaneous 
coronary intervention; SCAI = Society for Cardiac Angiography 
and Interventions.
TAbLE 3 
Characteristics of the procedure in patients who 
underwent primary PCI through radial access
n = 61
Sheath, n (%)
5 F 2 (3.3)
6 F 58 (95.1)
7 F 1 (1.6)
Crossover of access route, n (%) 3 (4.9)
Dt symptom onset-door, hours 5.5 ± 4.2
Door-to-balloon time, minutes 126.1 ± 44.7
Time of ischaemia, hours 8 ± 4.4
Contrast volume, mL* 121.2 ± 43.2
Fluoroscopy time, minutes* 16.1 ± 9.5
Procedure time, minutes* 48.3 ± 23.2
Abciximab, n (%) 23 (37.7) 
Thrombus aspiration catheter, n (%) 13 (21.3) 
Total lesions treated 71
Total stents implanted 77
Number of stents per patient 1.26 ± 0.23
Resolution of ST-segment elevation at 
90 minutes, n(%)
< 50% 21 (29.6)
> 50% 49 (70.5)
Angiographic success, % 98.5
* Includes coronary angiography and percutaneous coronary 
intervention. 
n = number of patients.
TAbLE 4 
Quantitative coronary angiography
n = 71
Pre-PCI
Reference diameter, mm 2.7 ± 0.7
Minimum luminal diameter, mm 0.6 ± 0.31
Stenosis diameter, % 91.2 ± 15.4
Lesion length, mm 14.5 ± 2.32
Post-PCI
Reference diameter, mm 2.9 ± 0.46
Minimum luminal diameter, mm 2.6 ± 0.43
Stenosis diameter, % 11.8 ± 11.6
Acute gain, mm 2.37 ± 0.59
PCI = percutaneous coronary intervention; n = number of 
lesions.
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discussion
In the authors’ experience, primary PCI through 
radial access is as effective as through femoral ac-
cess, with a high rate of technical success, low rate of 
crossover, and excellent safety, as the rates of bleeding 
and complications at the puncture site were practically 
absent in this sample. Many authors believe that the 
fluoroscopy time, an indirect measure of the difficulty 
of the procedure, is greater in PCI through radial ac-
cess than through femoral access. The present results 
were consistent with those described by Farman et al.9 
for PCI through radial access, and shorter than that 
demonstrated by Alli et al.10 for femoral access. It is 
important to mention that the surgeons must be familiar 
with the technique in order to achieve angiographic 
success and a low crossover rate of the access route 
in order to avoid delay of coronary reperfusion. In this 
center, the radial approach is the first choice for all 
procedures, whether therapeutic or diagnostic.
In patients with acute coronary syndrome, major 
bleeding is as common as recurrent infarction and 
occurs in approximately 5% of patients, depending on 
the definition used. A large proportion of the bleeding 
occurs at the vascular access site.11 Findings from seve ral 
studies suggest that major bleeding is associated with an 
increased risk of death and recurrent ischemic events.12,13 
Vascular access through the radial artery, which is a 
super ficial artery and easily compressible, results in lower 
rates of access site bleeding than the femoral artery. 
Furthermore, findings from observational studies suggest 
a lower risk of death and myocardial infarction when 
the procedure is performed through radial access.14,15
A series of studies compared the radial and femoral 
routes in different scenarios. The RadIal Vs. femorAL 
access for coronary intervention trial (RIVAL) has dem-
onstrated that, for surgeons with a high annual volume 
TAbLE 5 
Clinical outcomes up to 30 days of patients 
who underwent primary percutaneous coronary 
intervention through radial access
n = 61
Clinical success, n (%) 55 (90.2)
Death, n (%) 4 (6.6) 
Cardiac 3 (4.9) 
Non-cardiac 1 (1.6)
Stroke, n (%) 0
AMI Q, n (%) 2 (2.8) 
Percutaneous reintervention, n (%) 2 (2.8)
Stent subacute thrombosis, n (%) 2 (2.8) 
Acute renal failure, n (%) 3 (4.9) 
Bleeding TIMI criteria, n (%)
Minimum 2 (3.3) 
Minor 0
Major 1 (1.6) 
Bleeding BARC criteria, n (%)
1 1 (1.6)
2 1 (1.6)
3B 1 (1.6)
Surgical intervention due to  
bleeding, n (%)
1 (1.6)
Mean hospitalisation period, days 5.2 ± 5.8
BARC = Bleeding Academic Research Consortium;  
AMI = acute myocardial infarction; n = number of patients; 
TIMI = Thrombolysis In Myocardial Infarction.
TAbLE 6 
Drugs prescribed at hospital discharge
n = 57
ASA, n (%) 57 (100)
Clopidogrel, n (%) 56 (98.3) 
Prasugrel, n (%) 1 (1.7) 
ACEI/ARA, n (%) 50 (87.7) 
Statins, n (%) 57 (100) 
Beta-blocker, n (%) 55 (96.5) 
Diuretics, n (%) 6 (10.6) 
Calcium channel blockers, n (%) 5 (8.8)
ASA = acetylsalicylic acid; ARA = angiotensin receptor 
antagonist; ACEI = angiotensin-converting enzyme inhibitor; 
n = number of patients discharged.
TAbLE 7 
Late evolution of patients who underwent primary 
PCI through radial access
Variable n = 57
Mean follow-up, days 146.7 ± 116.5
Death, n (%) 2 (3.5)
Acute myocardial infarction, n (%) 0
Need for percutaneous 
reintervention, n (%)
12 (21)
Need for surgical  
reintervention, n (%)
5 (8.8)
Clinical restenosis, n (%) 4 (7.2)
n = number of patients.
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of PCI through radial access, patients with STEMI have 
benefited more from the radial than the femoral access 
with respect to both the composite endpoint of death, 
AMI, and stroke (P = 0.011) and death (P = 0.001).11 
The Prospective REgistry of Vascular Access in Inter-
ventions in Lazio region (PREVAIL) study showed best 
results with PCI through radial access in real world 
contemporary patients, demonstrating that the routine 
use of radial access was independently associated 
with a decreased risk of the primary endpoints, which 
were composed of major and minor bleeding, stroke 
and periprocedural complications of the vascular site 
(odds ratio [OR]: 0.37; 95% confidence interval [95% 
CI]: 0.16–0.84), as well as a decreased risk of the 
secondary endpoints, consisting of hospital death and 
reinfarction (OR: 0.14; 95% CI: 0.03–0.62).16 The Acute 
Catheterisation and Urgent Intervention Triage strategY 
(ACUITY) study has demonstrated that the transradial 
approach reduces the rate of major bleeding compared 
to femoral access in patients with acute coronary 
syndromes (3% vs. 8.4%; P = 0.03).17
Finally, in Brazil, Andrade et al.18 published a study 
with consecutive patients who underwent primary PCI 
through radial access and demonstrated that the per-
formance of this procedure by experienced surgeons is 
safe, with a virtual absence of severe vascular compli-
cations related to the puncture site, findings that were 
reproduced in our study.
study limitations
This study has limitations inherent to its retrospec-
tive and observational design. The number of patients in 
the sample was small, it did not have a control group 
with PCI performed through the femoral artery, and it 
was performed at a single centre.
conclusions
The use of the transradial approach in primary 
PCI is safe and effective and, if performed by surgeons 
who are familiar with the technique, has a high rate 
of technical success and a low risk of major bleeding, 
with no significant delay to reperfusion compared to 
historical data.
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